SummaryIn PTEN-mutated tumors, we show that PI3Kα activity is suppressed and PI3K signaling is driven by PI3Kβ. A selective inhibitor of PI3Kβ inhibits the Akt/mTOR pathway in these tumors but not in those driven by receptor tyrosine kinases. However, inhibition of PI3Kβ only transiently inhibits Akt/mTOR signaling because it relieves feedback inhibition of IGF1R and other receptors and thus causes activation of PI3Kα and a rebound in downstream signaling. This rebound is suppressed and tumor growth inhibition enhanced with combined inhibition of PI3Kα and PI3Kβ. In PTEN-deficient models of prostate cancer, this effective inhibition of PI3K causes marked activation of androgen receptor activity. Combined inhibition of both PI3K isoforms and...
Alterations in phosphatidylinositol 3-kinase (PI3K) and in PTEN (phosphatase and tensin homolog), th...
Many tumors have chronically elevated activity of PI 3-kinase-dependent signaling pathways, caused l...
Class I phosphoinositide 3-kinase (PI3K) generates phosphatidylinositol 3,4,5-trisphosphate (PtdIns(...
SummaryProstate cancer is characterized by its dependence on androgen receptor (AR) and frequent act...
The PI3K pathway is mutated in a substantial set of tumors which includes alterations in PIK3CA and ...
The PTEN tumor suppressor is among the most frequently altered genes of cancer. PTEN suppression at ...
The PI3K-Akt pathway is a major survival pathway activated in cancer. Efforts to develop targeted th...
Abstract Regulation of the PI-3 kinase (PI3K)/Akt signalling pathway is essential for maintaining th...
Deregulation of the PI3K signaling pathway is observed in many human cancers and occurs most frequen...
<div><p>Targeting the PI3K pathway has achieved limited success in cancer therapy. One reason for th...
PURPOSE: Inhibition of phosphoinositide 3 (PI3)-kinase pathway is attractive for cancer treatment. T...
Although the prognosis of patients with localized prostate cancer is good after surgery, with a favo...
The PI3K (phosphoinositide 3-kinase) pathway is commonly activated in cancer as a consequence of ina...
Understanding the mechanisms driving PI3K isoform dependency in prostate cancer can help the design ...
The PI3K–AKT–mTOR signal transduction pathway regulates a variety of biological processe...
Alterations in phosphatidylinositol 3-kinase (PI3K) and in PTEN (phosphatase and tensin homolog), th...
Many tumors have chronically elevated activity of PI 3-kinase-dependent signaling pathways, caused l...
Class I phosphoinositide 3-kinase (PI3K) generates phosphatidylinositol 3,4,5-trisphosphate (PtdIns(...
SummaryProstate cancer is characterized by its dependence on androgen receptor (AR) and frequent act...
The PI3K pathway is mutated in a substantial set of tumors which includes alterations in PIK3CA and ...
The PTEN tumor suppressor is among the most frequently altered genes of cancer. PTEN suppression at ...
The PI3K-Akt pathway is a major survival pathway activated in cancer. Efforts to develop targeted th...
Abstract Regulation of the PI-3 kinase (PI3K)/Akt signalling pathway is essential for maintaining th...
Deregulation of the PI3K signaling pathway is observed in many human cancers and occurs most frequen...
<div><p>Targeting the PI3K pathway has achieved limited success in cancer therapy. One reason for th...
PURPOSE: Inhibition of phosphoinositide 3 (PI3)-kinase pathway is attractive for cancer treatment. T...
Although the prognosis of patients with localized prostate cancer is good after surgery, with a favo...
The PI3K (phosphoinositide 3-kinase) pathway is commonly activated in cancer as a consequence of ina...
Understanding the mechanisms driving PI3K isoform dependency in prostate cancer can help the design ...
The PI3K–AKT–mTOR signal transduction pathway regulates a variety of biological processe...
Alterations in phosphatidylinositol 3-kinase (PI3K) and in PTEN (phosphatase and tensin homolog), th...
Many tumors have chronically elevated activity of PI 3-kinase-dependent signaling pathways, caused l...
Class I phosphoinositide 3-kinase (PI3K) generates phosphatidylinositol 3,4,5-trisphosphate (PtdIns(...